X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
oncology (9) 9
aged (7) 7
index medicus (7) 7
middle aged (7) 7
cancer (6) 6
chemotherapy (6) 6
adult (5) 5
clinical trials (5) 5
female (5) 5
male (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
care and treatment (4) 4
disease-free survival (4) 4
antineoplastic agents - therapeutic use (3) 3
breast cancer (3) 3
breast neoplasms - drug therapy (3) 3
cancer patients (3) 3
cancer therapies (3) 3
drug administration schedule (3) 3
hematology, oncology and palliative medicine (3) 3
prostate cancer (3) 3
prostatic neoplasms - drug therapy (3) 3
treatment outcome (3) 3
aged, 80 and over (2) 2
androgen antagonists - adverse effects (2) 2
animals (2) 2
bevacizumab (2) 2
breast neoplasms - pathology (2) 2
cisplatin (2) 2
clinical study (2) 2
drug dosages (2) 2
gynecomastia (2) 2
gynecomastia - drug therapy (2) 2
gynecomastia - radiotherapy (2) 2
hematology (2) 2
kaplan-meier estimate (2) 2
medicine (2) 2
metastasis (2) 2
mice (2) 2
mice, inbred balb c (2) 2
neoplasm staging (2) 2
paclitaxel - administration & dosage (2) 2
pain (2) 2
phase-ii trial (2) 2
product development (2) 2
quality of life (2) 2
risk factors (2) 2
tumors (2) 2
young adult (2) 2
1st-line (1) 1
1st-line therapy (1) 1
1st-line treatment (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
abemaciclib (1) 1
abridged index medicus (1) 1
acquired immunodeficiency syndrome - drug therapy (1) 1
acquired immunodeficiency syndrome - virology (1) 1
acquired-resistance (1) 1
active antiretroviral therapy (1) 1
adolescent (1) 1
algorithms (1) 1
ambulatory care (1) 1
analysis (1) 1
anastrozole (1) 1
ancient history (1) 1
androgen antagonists - therapeutic use (1) 1
anilides - adverse effects (1) 1
anthracycline (1) 1
antibiotics, antineoplastic - administration & dosage (1) 1
antibodies (1) 1
antibodies, neoplasm - blood (1) 1
antibody (1) 1
anticoagulants - administration & dosage (1) 1
antigens, neoplasm - analysis (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents, phytogenic - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
antiretroviral therapy, highly active (1) 1
antitumor-activity (1) 1
arts and literature (1) 1
bacteriophage lambda (1) 1
bacteriophage m13 - genetics (1) 1
bacteriophage-lambda (1) 1
baldness (1) 1
bayesian analysis (1) 1
benzodioxoles - pharmacology (1) 1
bicalutamide-induced gynecomastia (1) 1
biodegradable polymers (1) 1
biological products (1) 1
bleeding complications (1) 1
blotting, western (1) 1
body image (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 396 - 405
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1863 - 1872
Journal Article
Breast Cancer Research, ISSN 1465-5411, 05/2014, Volume 16, Issue 3, pp. R45 - R45
Introduction: Src tyrosine kinase overactivation has been correlated with a poor response to human epidermal growth factor receptor 2 (HER2) inhibitors in... 
IN-VITRO | EPITHELIAL-CELLS | TRASTUZUMAB | ONCOLOGY | PHOSPHORYLATION | ZD1839 IRESSA | ACQUIRED-RESISTANCE | FAMILY KINASES | TYROSINE KINASE INHIBITOR | ANTITUMOR-ACTIVITY | HER2 | Neoplasm Transplantation | Humans | Receptor, ErbB-2 - metabolism | Cell Survival - genetics | Drug Resistance, Neoplasm | Transplantation, Heterologous | Cell Movement - genetics | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Receptor, Epidermal Growth Factor - metabolism | Lung Neoplasms - secondary | RNA Interference | src-Family Kinases - metabolism | Female | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | src-Family Kinases - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Drug Synergism | Cell Movement - drug effects | Animals | Lung Neoplasms - prevention & control | Breast Neoplasms - pathology | Mice, Nude | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | RNA, Small Interfering | Enzyme Activation | Neoplasm Invasiveness - genetics | Quinazolines - pharmacology | src-Family Kinases - genetics | Benzodioxoles - pharmacology | Tyrosine | Analysis | Metastasis
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2011, Volume 67, Issue 6, pp. 1455 - 1461
Journal Article
Journal Article
Oncology, ISSN 0030-2414, 10/2002, Volume 63, Issue 3, pp. 219 - 225
Background and Aim: In vitro, methotrexate (MTX) is the best modulator for bolus 5-fluorouracil (5FU), whereas folinic acid (FA) is the best for continuous... 
Clinical Study
Journal Article